Screener
Insulet PODD Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Insulet’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
| (in millions, except share and per share data) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (note 11) | ||
| Stockholders’ Equity | ||
| Preferred stock, $0.001 par value, 5,000,000 authorized; none issued and outstanding | — | — |
| Common stock, $0.001 par value,100,000,000 authorized; 70,798,932 and 70,588,192 issued | 0.1 | 0.1 |
| Additional paid-in capital | 1,309.0 | 1,274.9 |
| Accumulated earnings | 473.5 | 287.4 |
| Accumulated other comprehensive income | 1.9 | 12.5 |
| Treasury stock, at cost; 1,447,918 and 197,374 shares | (363.5) | (60.4) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Insulet's common stock?
- Insulet (PODD) reported common stock of 100M in Q2 2026.
- How has Insulet's common stock changed year-over-year?
- Insulet's common stock decreased by 0.0% year-over-year, from 100M to 100M.
- What is the long-term trend for Insulet's common stock?
- Over 5 years (2020 to 2025), Insulet's common stock has grown at a 298.1% compound annual growth rate (CAGR), from 100K to 100M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Insulet's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude